slotkoers
Ho Chi Minh S.E.
00:00:00 10-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
28.800
VND
|
-0,69%
|
|
+5,49%
|
+15,20%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
531.387
|
1.591.319
|
1.432.187
|
2.341.546
|
1.789.505
|
1.826.026
|
Bedrijfswaarde
1 |
713.419
|
1.670.824
|
1.709.928
|
2.507.773
|
2.141.450
|
2.338.444
|
K/w-verhouding
|
42,4
x
|
22,5
x
|
26,1
x
|
26,6
x
|
15,4
x
|
29,6
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
0,66
x
|
2,12
x
|
2,13
x
|
3,33
x
|
1,76
x
|
1,6
x
|
Bedrijfswaarde/omzet
|
0,89
x
|
2,22
x
|
2,55
x
|
3,56
x
|
2,11
x
|
2,04
x
|
Bedrijfswaarde/EBITDA
|
13,8
x
|
32
x
|
22,4
x
|
20,7
x
|
12,9
x
|
21,5
x
|
Bedrijfswaarde/FCF
|
-3,24
x
|
-14,1
x
|
-3,38
x
|
-8,06
x
|
-2,63
x
|
-12,5
x
|
FCF Yield
|
-30,9%
|
-7,07%
|
-29,6%
|
-12,4%
|
-38%
|
-8,03%
|
Price to Book
|
0,71
x
|
1,9
x
|
1,59
x
|
2,41
x
|
1,3
x
|
1,27
x
|
Aantal aandelen (in duizenden)
|
56.833
|
56.833
|
56.833
|
58.833
|
73.041
|
73.041
|
Referentieprijs
2 |
9.350
|
28.000
|
25.200
|
39.800
|
24.500
|
25.000
|
Datum van publicatie
|
15/03/19
|
30/03/20
|
31/03/21
|
28/01/22
|
30/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
804.180
|
752.014
|
671.246
|
703.634
|
1.015.686
|
1.143.946
|
EBITDA
1 |
51.777
|
52.255
|
76.184
|
120.888
|
166.302
|
108.737
|
Bedrijfsresultaat (EBIT)
1 |
10.752
|
12.788
|
47.904
|
86.781
|
128.285
|
70.726
|
Operationele Marge
|
1,34%
|
1,7%
|
7,14%
|
12,33%
|
12,63%
|
6,18%
|
Resultaat voor belastingen (EBT)
1 |
20.028
|
104.733
|
85.944
|
110.284
|
141.542
|
78.111
|
Nettowinst (verlies)
1 |
12.535
|
88.474
|
66.391
|
85.961
|
111.641
|
61.717
|
Nettomarge
|
1,56%
|
11,76%
|
9,89%
|
12,22%
|
10,99%
|
5,4%
|
WPA
2 |
220,6
|
1.244
|
966,2
|
1.495
|
1.591
|
845,0
|
Free Cash Flow
1 |
-220.456
|
-118.140
|
-505.849
|
-310.957
|
-814.492
|
-187.823
|
FCF-marge
|
-27,41%
|
-15,71%
|
-75,36%
|
-44,19%
|
-80,19%
|
-16,42%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15/03/19
|
30/03/20
|
31/03/21
|
28/01/22
|
30/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
182.032
|
79.505
|
277.741
|
166.227
|
351.945
|
512.418
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
3,516
x
|
1,521
x
|
3,646
x
|
1,375
x
|
2,116
x
|
4,712
x
|
Free Cash Flow
1 |
-220.456
|
-118.140
|
-505.849
|
-310.957
|
-814.492
|
-187.823
|
ROE (netto-inkomsten/eigen vermogen)
|
1,59%
|
10,3%
|
7,43%
|
8,81%
|
9,59%
|
4,37%
|
ROA (netto-inkomsten/totale activa)
|
0,46%
|
0,46%
|
1,7%
|
3,03%
|
4,13%
|
2,02%
|
Totale activa
1 |
2.753.636
|
19.059.391
|
3.895.044
|
2.838.109
|
2.705.724
|
3.059.709
|
Nettoactief per aandeel
2 |
13.171
|
14.726
|
15.863
|
16.492
|
18.806
|
19.610
|
Cashflow per aandeel
2 |
398,0
|
255,0
|
737,0
|
701,0
|
724,0
|
322,0
|
Capex
1 |
102.686
|
10.515
|
101.948
|
152.612
|
233.028
|
222.874
|
Capex/omzet
|
12,77%
|
1,4%
|
15,19%
|
21,69%
|
22,94%
|
19,48%
|
Datum van publicatie
|
15/03/19
|
30/03/20
|
31/03/21
|
28/01/22
|
30/03/23
|
28/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +15,20% | 83,25 mln. | | +30,64% | 695 mld. | | +26,51% | 568 mld. | | -4,62% | 361 mld. | | +19,62% | 330 mld. | | +3,79% | 283 mld. | | +16,70% | 239 mld. | | +8,78% | 204 mld. | | -7,93% | 198 mld. | | +7,92% | 168 mld. |
Farmaceutische producten - Andere
|